Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul 31;511(7511):557-62.
doi: 10.1038/nature13396. Epub 2014 Jul 6.

Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain

Affiliations

Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain

Andrew S Doré et al. Nature. .

Abstract

Metabotropic glutamate receptors are class C G-protein-coupled receptors which respond to the neurotransmitter glutamate. Structural studies have been restricted to the amino-terminal extracellular domain, providing little understanding of the membrane-spanning signal transduction domain. Metabotropic glutamate receptor 5 is of considerable interest as a drug target in the treatment of fragile X syndrome, autism, depression, anxiety, addiction and movement disorders. Here we report the crystal structure of the transmembrane domain of the human receptor in complex with the negative allosteric modulator, mavoglurant. The structure provides detailed insight into the architecture of the transmembrane domain of class C receptors including the precise location of the allosteric binding site within the transmembrane domain and key micro-switches which regulate receptor signalling. This structure also provides a model for all class C G-protein-coupled receptors and may aid in the design of new small-molecule drugs for the treatment of brain disorders.

PubMed Disclaimer

References

    1. J Mol Biol. 2009 Jul 10;390(2):262-77 - PubMed
    1. Nature. 2013 Jul 25;499(7459):438-43 - PubMed
    1. Trends Biochem Sci. 2009 Nov;34(11):540-52 - PubMed
    1. Neuropharmacology. 2011 Jan;60(1):36-44 - PubMed
    1. Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):378-83 - PubMed

Substances

Associated data